Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients

Al‑Kafaji,Ghada; Aljadaan,Abdulah; Kamal,Amer; Bakhiet,Moiz

doi:10.3892/etm.2018.6319

Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients

Authors:
- Ghada Al‑Kafaji
- Abdulah Aljadaan
- Amer Kamal
- Moiz Bakhiet
View Affiliations

Affiliations: Department of Molecular Medicine and Al‑Jawhara Centre for Molecular Medicine, Genetics and Inherited Disorders, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329, Kingdom of Bahrain, Department of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329, Kingdom of Bahrain
Published online on: June 15, 2018 https://doi.org/10.3892/etm.2018.6319
Pages: 1483-1492

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The mitochondrial DNA copy number (mtDNA‑CN) is a surrogate measure of mitochondrial function and altered mtDNA‑CN reflects the oxidant‑induced cell damage. A previous study by our group demonstrated that a reduction in the renal mtDNA‑CN is implicated in the pathogenesis of diabetic nephropathy (DN), a leading cause of end‑stage renal disease in diabetic patients. In the present study, it was investigated whether the mtDNA‑CN in the peripheral blood may be utilized as a biomarker for DN in type 2 diabetes (T2D) patients. The study included 50 non‑diabetic and 100 diabetic subjects. The diabetic subjects were sub‑divided based on their albumin‑to‑creatinine ratio (ACR) into T2D patients with normoalbuminuria (n=50), DN patients with microalbuminuria (n=29) and DN patients with macroalbuminuria (n=21). The mtDNA‑CN was measured in the peripheral blood by real‑time polymerase chain reaction analysis. Patients with DN had a lower mtDNA‑CN than patients with T2D and healthy controls (P<0.05). A sub‑group analysis with stratification by the ACR indicated that a decreased mtDNA‑CN was associated with the severity and the presence of DN, as it was lower in DN patients with macroalbuminuria than in DN patients with microalbuminuria and T2D patients with normoalbuminuria (P<0.01). The area under the receiver operating characteristic curve (AUC) for mtDNA‑CN was 0.916 (sensitivity, 86% and specificity, 74%) and 0.961 (sensitivity, 96% and specificity, 88%) for differentiating DN patients from T2D patients without DN and from healthy controls, respectively. Furthermore, the AUC of mtDNA‑CN for differentiating DN patients with microalbuminuria from those with macroalbuminuria was 0.895 (sensitivity, 83% and specificity, 85%). Multivariate analysis revealed that the mtDNA‑CN was significantly associated with the occurrence and progression of DN, even after adjustment for age, mean blood pressure, glycated haemoglobin A1c and total cholesterol (P<0.05). In patients with DN, a decreased mtDNA‑CN was negatively correlated with albuminuria and conventional risk factors for DN, and was positively correlated with the estimated glomerular filtration rate. The present results therefore suggest the utilization of circulating mtDNA‑CN as a novel biomarker for the early diagnosis of DN and indicate the significance of decreased mtDNA‑CN as another independent risk factor for DN.

View Figures

View References

1	Wild S, Roglic G, Green A, Sicree R and King H: Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 27:1047–1053. 2004. View Article : Google Scholar : PubMed/NCBI
2	Ghaderian SB, Hayati F, Shayanpour S and Mousavi SSB: Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev. 4:28–33. 2015.PubMed/NCBI
3	Ritz E and Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 341:1127–1133. 1999. View Article : Google Scholar : PubMed/NCBI
4	Remuzzi G and Ruggenenti P: Slowing the progression of diabetic nephropathy. N Engl J Med. 329:1496–1497. 1993. View Article : Google Scholar : PubMed/NCBI
5	Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G and Zinman B: DCCT/EDIC Research Group; Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Advances and contributions. Diabetes. 62:3976–3985. 2013. View Article : Google Scholar : PubMed/NCBI
6	Implications of the diabetes control complications trial. American diabetes association. Diabetes. 42:1555–1558. 1993. View Article : Google Scholar : PubMed/NCBI
7	Forbes JM, Coughlan MT and Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 57:1446–1454. 2008. View Article : Google Scholar : PubMed/NCBI
8	Sivitz WI and Yorek MA: Mitochondrial dysfunction in diabetes: From molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 12:537–577. 2010. View Article : Google Scholar : PubMed/NCBI
9	Nishikawa T, Edelstein D, Du X L, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404:787–790. 2000. View Article : Google Scholar : PubMed/NCBI
10	Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813–820. 2001. View Article : Google Scholar : PubMed/NCBI
11	Arora MK and Singh UK: Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update. Vascul Pharmacol. 58:259–271. 2013. View Article : Google Scholar : PubMed/NCBI
12	Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V and Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia. 20:457–461. 1981. View Article : Google Scholar : PubMed/NCBI
13	Maclsaac RJ, Ekinici E and Jerums G: Progressive diabetic nephropathy. How useful is microalbuminuria? Contra'. Kidney Int. 86:50–57. 2014.
14	Glassock RJ: Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep. 12:364–368. 2010. View Article : Google Scholar : PubMed/NCBI
15	Rigalleau V, Lasseur C, Raffaitin C, Beauvieux MC, Barthe N, Chauveau P, Combe C and Gin H: Normoalbuminuric renal-insufficient diabetic patients. Diabetes Care. 30:2034–2039. 2007. View Article : Google Scholar : PubMed/NCBI
16	Clay-Montier LL, Deng JJ and Bai Y: Number matters: Control of mammalian mitochondrial DNA copy number. J Genet Genomics. 36:125–131. 2009. View Article : Google Scholar : PubMed/NCBI
17	Santos JH, Hunakova L, Chen Y, Bortner C and Van Houten B: Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J Biol Chem. 278:1728–1734. 2003. View Article : Google Scholar : PubMed/NCBI
18	Lee HC and Wei YH: Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochemy and Cell Biol. 37:822–834. 2005. View Article : Google Scholar
19	Al-Kafaji G and Golbahar J: High glucose-induced oxidative stress increases the copy number of mitochondrial DNA in human mesangial cells. Biomed Res Int. 2013:7549462013. View Article : Google Scholar : PubMed/NCBI
20	Al-Kafaji G, Sabry MA and Bakhiet M: Increased expression of mitochondrial DNA-encoded genes in human renal mesangial cells in response to high glucose-induced reactive oxygen species. Mol Med Rep. 13:1774–1780. 2016. View Article : Google Scholar : PubMed/NCBI
21	Al-Kafaji G, Sabry MA and Skrypnyk C: Time-course effect of high glucose-induced reactive oxygen species on mitochondrial biogenesis and function in human renal mesangial cells. Cell Biol Int. 40:36–48. 2016. View Article : Google Scholar : PubMed/NCBI
22	Lee H, Song JH, Shine CS, Park DJ, Park KS, Lee KU and Koh CS: Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 42:161–167. 1998. View Article : Google Scholar : PubMed/NCBI
23	Gianotti TF, Sookoian S, Dieuzeide G, Garcia S, Gemma C, González CD and Pirola CJ: A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring). 16:1591–1595. 2008. View Article : Google Scholar : PubMed/NCBI
24	Song J, Oh JY, Sung YA, Pak YK, Park KS and Lee HK: Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. Diabetes Care. 24:865–869. 2001. View Article : Google Scholar : PubMed/NCBI
25	Xu FX, Zhou X, Shen F, Pang R and Liu SM: Decreased peripheral blood mitochondrial DNA content is related to HbA1c, fasting plasma glucose level and age of onset in type 2 diabetes mellitus. Diabet Med. 29:e47–e54. 2012. View Article : Google Scholar : PubMed/NCBI
26	Hu L, Yao X and Shen Y: Altered mitochondrial DNA copy number contributes to human cancer risk: Evidence from an updated meta-analysis. Sci Rep. 6:358592016. View Article : Google Scholar : PubMed/NCBI
27	Liu LP, Cheng K, Ning MA, Li HH, Wang HC, Li F, Chen SY, Qu FL and Guo WY: Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease. Atherosclerosis. 261:105–110. 2017. View Article : Google Scholar : PubMed/NCBI
28	Alberti KG and Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15:539–553. 1998.
29	Mattix HJ, Hsu CY, Shaykevich S and Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol. 13:1034–1039. 2002.PubMed/NCBI
30	Stoves J, Lindley EJ, Barnfield MC, Burniston MT and Newstead CG: MDRD equation estimates of glomerular filtration rate in potential living kidney donors and renal transplant recipients with impaired graft function. Nephrol Dial Transplant. 17:2036–2037. 2002. View Article : Google Scholar : PubMed/NCBI
31	Lee JE, Park H, Ju YS, Kwak M, Kim J, Oh HY and Seo JS: Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria. Exp Mol Med. 41:253–258. 2009. View Article : Google Scholar : PubMed/NCBI
32	Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N and Takeshita A: Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 88:529–535. 2001. View Article : Google Scholar : PubMed/NCBI
33	Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC and Trimble ER: Glucose-induced oxidative stress in mesangial cells. Kidney Int. 61:599–608. 2002. View Article : Google Scholar : PubMed/NCBI
34	Ha H and Lee HB: Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton). 10 Suppl:S7–S10. 2005. View Article : Google Scholar : PubMed/NCBI
35	Kakimoto M, Inoguchi T Sonta T, Yu HY, Imamura M, Etoh T, Hashimoto T and Nawata H: Accumulation of 8-hydroxy-2-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 51:1588–1595. 2002. View Article : Google Scholar : PubMed/NCBI
36	Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu WH, Qu NQ, Liang MH and Chang D: The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol. 47 Suppl 1:S71–S76. 2010. View Article : Google Scholar
37	Inci A, Olmaz R, Sarı F, Coban M, Ellidag HY and Sarıkaya M: Increased oxidative stress in diabetic nephropathy and its relationship with soluble Klotho levels. Hiprokratia. 20:198–203. 2016.
38	Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, Ping F, Li W and Li Y: Reduced peripheral blood mtDNA content is associated with impaired glucose-stimulated islet β cell function in a Chinese population with different degrees of glucose tolerance. Diabetes Metab Res Rev. 32:768–774. 2016. View Article : Google Scholar : PubMed/NCBI
39	Duran-Salgado MB and Rubio-Guerra AF: Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398. 2014. View Article : Google Scholar : PubMed/NCBI
40	Cherry AD and Piantadosi CA: Regulation of mitochondrial biogenesis and its intersection with inflammatory responses. Antioxid Redox Signal. 22:965–976. 2015. View Article : Google Scholar : PubMed/NCBI
41	Chawla A, Nguyen KD and Goh YP: Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 11:738–749. 2011. View Article : Google Scholar : PubMed/NCBI
42	Wu IC, Lin CC, Liu CS, Hus CC, Chen CY and Hsiung CA: Interrelations between mitochondrial DNA copy number and inflammation in older adults. J Gerontol A Biol Sci Med Sci. 72:937–944. 2017. View Article : Google Scholar : PubMed/NCBI
43	Cossarizza A: Tests for mitochondrial function and DNA: Potentials and pitfalls. Curr Opin Infect Dis. 16:5–10. 2003. View Article : Google Scholar : PubMed/NCBI
44	Hurtado-Roca Y, Ledesma M, Gonzalez-Lazaro M, Moreno-Loshuertos R, Fernandez-Silva P, Enriquez JA and Laclaustra M: Adjusting MtDNA quantification in whole blood for peripheral blood platelet and leukocyte counts. PLoS One. 11:e01637702016. View Article : Google Scholar : PubMed/NCBI
45	Steinberg K, Beck J, Nickerson D, Garcia-Closas M, Gallagher M, Caggana M, Reid Y, Cosentino M, Ji J, Johnson D, et al: DNA banking for epidemiologic studies: A review of current practices. Epidemiology. 13:246–254. 2002. View Article : Google Scholar : PubMed/NCBI
46	Xia P, An H-X, Dang C-X, Radpour R, Kohler C, Fokas E, Engenhart-Cabillic R, Holzgreve W and Zhong XY: Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer. 9:4542009. View Article : Google Scholar : PubMed/NCBI
47	Demmer RT, Zuk AM, Rosenbaum M and Desvarieux M: Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: Results from the continuous NHANES, 1999-2010. Am J Epidemiol. 178:1106–1113. 2013. View Article : Google Scholar : PubMed/NCBI
48	Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, et al: Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6,958 patients in the Danish DD2 cohort. J Diabetes Complications. 32:34–40. 2018. View Article : Google Scholar : PubMed/NCBI
49	Cho SB, Koh I, Nam HY, Jeon JP, Lee HK and Han BG: Mitochondrial DNA copy number augments performance of A1C and oral glucose tolerance testing in the prediction of type 2 diabetes. Sci Rep. 7:432032017. View Article : Google Scholar : PubMed/NCBI
50	Rao M, Li L, Demello C, Guo D, Jaber BL, Pereira BJ and Balakrishnan VS: HEMO Study Group; Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Sco Nephrol. 20:189–196. 2009. View Article : Google Scholar
51	Mishra M, Lillvis J, Seyoum B and Kowluru RA: Peripheral blood mitochondrial DNA damage as a potential noninvasive biomarker of diabetic retinopathy. Invest Ophthalmol Vis Sci. 57:4035–4044. 2016. View Article : Google Scholar : PubMed/NCBI
52	Jayakumar RV: Risk factors in diabetic nephropathy. Int J Diabetes Dev Ctries. 32:1–3. 2012. View Article : Google Scholar
53	Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T and Ahbap E: Risk factors for progression of renal disease in patient with diabetic nephropathy. Eur Rev Med Pharmacol Sci. 16:878–883. 2012.PubMed/NCBI